chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a immunization coordinator concerning a 69 year old female with no medical history or allergies who on 11-MAY-2007 at 9:30 Am, was vaccinated SC on arm with a dose of Zostavax (Oka/Merck) (lot # 657558/0461U). There was no illnes at the time of vaccination within 24 hours, after vaccination the patient developed a quarter inch welt at injection site.  The welt lasted for 10 days and then resolved.  Unspecified medical attention was sought.  At the time of report the patient had recovered.  A product quality complaint was not involved.  Additional information has been received from a immunization coordinator who stated that the patient developed a rash on arm within 24 hours of vaccination. No diagnostic laboratory tests were undertaken. On 14-MAY-2007 the patient had recovered. No information is expected.
I experienced heart palpations which I was later told were PVC's. These were happening randomly but it was often enough that I ended up seeing a cardiologist and I have been put on a medication for them. This did happen again when I had my booster and they kicked up but over time calmed down as well.
Patient stated after waiting 15 minutes she felt dizzy. Declined to sit in a recliner and was offered two gatorades. After sitting for an additional 10 minutes she denied feelings of diziness.
Breakthrough varicella zoster infection in the setting of immunosuppression due to chemotherapy (T-cell ALL) that started in Oct 2022. Symptoms began in Nov 2022 with skin rash on leg. No known exposure history. Admitted to the hospital and treated with IV acyclovir.
Received vaccine on Friday, February 19, 2021. That night woke up at 4 am with a cold, couldn't breath.  Took nose drops and Advil.  fell back to sleep and woke up 5-6 hours later and felt fine. Saturday night same thing but this time it was flu symptoms, no fever.  Took Advil and woke up 5 hours later and felt fine. Sunday started to have diarrhea that lasted 2 days, blood pressure started to rise at night, and had a rash at injection site.  BP did not go up as high as after the first injection and it may have been because I was still on the 5 mg of Amlodipine.  After 3 days BP started to go back to normal.  Rash lasted 3 days this time.
died from the vaccine; This is a spontaneous report from a contactable consumer reporting same event under the same suspect product for 4 patients. This is one of four reports. A patient of unspecified age and gender received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) at single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced died from the vaccine on an unspecified date. The reporter stated in his neighborhood 4 people died from the vaccine. The patient died on an unspecified date. It was not reported if an autopsy was performed.  Follow-up attempts have been completed and no further information is expected. Information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202100912595 same reporter, event and drug, different patient; Reported Cause(s) of Death: died from the vaccine
Patient complained of chest pain this morning around 10 am.  He described it as sudden pain on the midsternal area stomping in character, lasted 1 hour then stopped for a few minutes then came back again. He has no difficulty of breathing, no sudden coughing, no wheezing, no dizziness, no cyanosis, no pallor. He denies any trauma on his chest nor recent exercises involving his chest. He was not lifting heavy objects. He states he was lying down when it happened. Pain was 5/10. He received his second Pfizer Covid 19 vaccine 2 days ago.
first dose Dic 2021, appointment for second next week; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in December 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 20-Sept-2022 Reporter's comment: The pharmacist called to receive some guidance on Shigrix schedule because she had a patient that has an appointment for the second dose next week.  There were 10 month apart instead of 6. The reporter did not consent to follow-up. Additional supportive information: Till time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
I woke up with a severe rash on the left arm from the top of the deltoid down through the triceps area all the way to the elbow. Rash was red and bumpy, itchy, and warm to the touch.  treated with OTC oral Benadryl and hydrocortisone ointment.
2 cold sores on the outer lip, lower left and lower left-center, with dry, chapped lips which had not been present previous to shot through this winter season. Treated topically with rose ointment and other lip moisturizers, kept clean.  Still on last stages of healing 12 days later but no longer spontaneously cracking/bleeding with lip movement.
Bell's palsy; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of BELL'S PALSY (Bell's palsy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BELL'S PALSY (Bell's palsy) (seriousness criterion medically significant). At the time of the report, BELL'S PALSY (Bell's palsy) outcome was unknown. Not Provided          No concomitant and treatment medications were reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Follow-up information contains non-significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I got a chest cold, I.E., tightness in chest and fatigue. My throat is also little sore (voice much lower).
I received my Covid vaccine on 05/20/2022. On the afternoon of 05/30/2022 I started feeling sore throat nasal congestion, fatigue, and mild headache. I then took an home Covid test and was diagnosed for Covid on 06/01/2022. I then reached out to my doctor and was prescribed PAXLOVID. I took the PAXLOVID for 5 days and the symptoms went down. I retested 06/06/2022 and was negative. I had then accumulated sides effects from the medication PAXLOVID.
within about 15 minutes of receiving vaccine, tip of client's tongue began to feel numb. Declined benadryl, continued to be monitored by EMS. Felt warm/flushed in 78F room but without hives/rash/tongue or throat swelling/itching/other signs of allergic rxn. No history of allergic reaction and no issues with first dose of vaccine. Declined transport and medication. Monitored for over an hour by EMS without any worsening of symptoms.
This is a spontaneous report from a contactable consumer reporting for herself. A 65-years-old female patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration in Apr2017 at single dose for immunisation. Medical history included ongoing rheumatoid arthritis. The patient's concomitant medications were not reported. The patient experienced nauseous, chills, joint pain, muscle pain, been feeling really bad, had a cough in the morning when she got up, very tired and no appetite, all on an unspecified date with outcome of unknown. The events were described as following. She had no fever, no vomiting but she was nauseous and had chills. The joint pain and muscle pain was what was most bothersome to her at the current time and did not know if it was related to her rheumatoid arthritis or the vaccination. She planned to discuss this further with her physician. The patient wondered if she should have received the vaccine because she already had an autoimmune disease called rheumatoid arthritis.
24 hrs. after vaccine MENACTRA, GARADSIL administered pt developed hives itching & hot flashes.
Inflammation at injection site that is increasing in size as of day 2; It is painful/hot to touch and mildly itchy.; It is painful/hot to touch and mildly itchy.; It is painful/hot to touch and mildly itchy.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 41 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 11Oct2021 (Lot number: FE3590) at the age of 41 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Migraine" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: FLU, administration date 07Oct2021; TRIPTAN [OXITRIPTAN]; NAPROXEN; BIOTIN; VITAMIN D [VITAMIN D NOS]; VITAMIN B12 [CYANOCOBALAMIN]. Past drug history included: Bactrim, reaction(s): "Known allergies: Bactrim"; Bacitraicin, reaction(s): "Known allergies: Bacitraicin". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EN6201), administration date: 21Feb2021, when the patient was 40 years old, for Covid-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL9262), administration date: 31Jan2021, when the patient was 40 years old, for Covid-19 Immunization. The following information was reported: VACCINATION SITE INFLAMMATION (non-serious) with onset 12Oct2021, outcome "recovering", described as "Inflammation at injection site that is increasing in size as of day 2"; VACCINATION SITE PAIN (non-serious), VACCINATION SITE WARMTH (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 12Oct2021, outcome "recovering" and all described as "It is painful/hot to touch and mildly itchy.". Therapeutic measures were not taken as a result of vaccination site inflammation, vaccination site pain, vaccination site warmth, vaccination site pruritus.  Additional information: Patient received other vaccine in four weeks. Inflammation at injection site that is increasing in size as of day 2. It is painful/hot to touch and mildly itchy. No covid prior vaccination. Patient did not tested covid post vaccination.  Follow-up attempts are completed. No further information is expected.
Information has been received from a registered nurse concerning a 24 month old male who on 01/24/02 was vaccinated with a dose of Varivax (site unknown). On 02/05/2002 the patient developed a rash near the injection site, defined as "Varicella vaccine related rash" It was reported to be isolated to the site of vaccination. The patient sought unspecified attention. There were no other details available. Additional information is available.
a small red spot; it was tender; it got itchy and larger; a very small amount of redness; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (a small red spot), TENDERNESS (it was tender), PRURITUS (it got itchy and larger) and ERYTHEMA (a very small amount of redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041(6 or L)20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN, OMEPRAZOLE and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (a small red spot), TENDERNESS (it was tender), PRURITUS (it got itchy and larger) and ERYTHEMA (a very small amount of redness). At the time of the report, RASH MACULAR (a small red spot), TENDERNESS (it was tender), PRURITUS (it got itchy and larger) and ERYTHEMA (a very small amount of redness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   This case was linked.
Patient received the Pfizer COVID-19 vaccine as their second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-May-2021, the patient started TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (Intramuscular) 1 dosage form. On 30-May-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose). On 30-May-2021, INTERCHANGE OF VACCINE PRODUCTS (Patient received the Pfizer COVID-19 vaccine as their second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient has not reported any side effects or symptoms after the first or second vaccination. The pharmacist asked whether the patient would require an additional vaccine dose of the Moderna COVID-19 vaccine to complete the series for the patient after being given one dose of the Moderna COVID-19 vaccine and one dose of the Pfizer COVID-19 vaccine.
She was told it is covid arm,a delayed reaction in the skin; A delayed reaction in the skin; Severe pain in her arm; Itches like crazy; a small nut since at the injection site, which on 02Sep2021 it got bigger; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (She was told it is covid arm,a delayed reaction in the skin), SKIN REACTION (A delayed reaction in the skin), VACCINATION SITE SWELLING (a small nut since at the injection site, which on 02Sep2021 it got bigger), VACCINATION SITE PAIN (Severe pain in her arm) and VACCINATION SITE PRURITUS (Itches like crazy) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced VACCINATION SITE SWELLING (a small nut since at the injection site, which on 02Sep2021 it got bigger). On 02-Sep-2021, the patient experienced VACCINATION SITE REACTION (She was told it is covid arm,a delayed reaction in the skin), SKIN REACTION (A delayed reaction in the skin), VACCINATION SITE PAIN (Severe pain in her arm) and VACCINATION SITE PRURITUS (Itches like crazy). At the time of the report, VACCINATION SITE REACTION (She was told it is covid arm,a delayed reaction in the skin), SKIN REACTION (A delayed reaction in the skin), VACCINATION SITE SWELLING (a small nut since at the injection site, which on 02Sep2021 it got bigger), VACCINATION SITE PAIN (Severe pain in her arm) and VACCINATION SITE PRURITUS (Itches like crazy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
PFIZER-BIONTECH COVID-19 VACCINE EUA.  ADMINISTRATION ERROR- MIXED DOSE SERIES.  Patient received Moderna series for 1st and 2nd dose on 3/10/21 and 4/7/21 respectively.  Nursing facility and/or patient attests is immunocompromised and needs an additional dose.  Due to exceptional circumstances, patient cannot leave nursing facility to obtain Moderna for 3rd dose. Patient was vaccinated on 8/26/21 with Pfizer for additional dose for immunocompromised.
After receiving the vaccine, within 10 minutes I passed out. They put ice on my head and had me wait an additional 10 minutes. A week later I begin having arm pain. My arm would twitch and would have periodical pain. It took five months for me to have my menstrual cycle.
devel facial flushing, inconsolable crying w/in 2hr of vax;
My son was diagnosed by a Child Psychiatrist as PDD-NOS on the autistic spectrum around 7/02.  He still retains that diagnosis.    He was diagnosed with ulderative colitis and other GI complication via colonscopy 5/03.  Started medicine Sulfasalazine 6/7/03.  Too early to see any change, medicine to be taken for at least 1 year.  Treatment - Complete DAN protocol of supplements, prescription meds, Auditory Integration Training, Neurofeedback, OT, speech, PT, ABA for almost a total of 40 hours a week.
Had vaccination on 12/7, called clinic 12/9 for tenderness and redness to (R) leg. Assessment: Erythematous, indurated, tender area on (R) thigh - measures 7.5 cm with surrounding outer circle of erythema measuring 10 cm. No fluctuance or streaking. Antibiotics x 10 days. BENADRYL x 2 doses.
I had a sore arm. I had a really bad headache and a serve fever.  I had to sleep it off for at least 3-4 hrs. I am due January 16th.
Pfizer-BioNTech COVID-19 Vaccine EUA: One day after receving vaccine patient presented to the emergency department reporting fever (up to 100 degrees Fahrenheit), nausea, vomiting (resulting in sore throat),  diarrhea, fatigue, and body aches that started one day after after vaccine administration. Patient took acetaminophen prior to coming to the emergency department. Vital signs were blood pressure 131/85 mmHg, pulse 93 beats per minute, respiratory rate 16 breaths per minute, temperature 35.9 degrees Celcius, and oxygen saturation 95% on room air. On exam patient was awake, alert, and oriented times three, speaking in full sentances, and without repiratory distress or chest pain. The patient had no known COVID-19 positive contacts. Intravenous fluids and one dose of ondansetron were administered with  significant symptom improvement and patient tolerated oral fluids.  Patient was discharged from the emergency department to home ambulatory in stable condition. Provider stated most likely etiology of symptoms was gastroenteritis.
Dizziness and tingling sensation vital sgns= 133/77, HR 70, Sp02 99%  Seen and cleared
Symptom: injection site pain (1 hour onset, gradually dissipating but still sore at 42 hours) Symptoms: General muscle soreness, general fatigue  onset around  27 hours Treatment: 2x 500mg Tylenol, hot shower, sleep for 14 hours,  Time Course: much less soreness upon awakening, no fatigue
Warm to touch, redness, right thigh - x 1 week. Acetaminophin 100 mg; 5ml Q daily, Cetirizine 5 mg, 5 ml Q PRN.
Patient had received covid vaccine, and had been monitored her full fifteen minutes. Time ended at 11:56. Left facility, voicing no concerns and reentered building at 12:13, complaining of hives.  Alert, oriented, and not in any acute distress. Hives noted to bottom of chin, neck and chest area. 12: 15 Brought to cot area, where I was met by.  Patient stated she had a reaction to first vaccination so had already taken a Benadryl 25mg this am at 9:45. She also had taken a dose of Benadryl after leaving facility at noon. Total dose 50mg. Blood pressure 182/118 hr 145, r 22 sat 98%. Explained unable to give Benadryl as already had taken max dose for 4 hours, and unable to give epi since b/p and hr so high. 12:15 contacted EMS per protocol. 12:20 vitals 188/110 hr 128 r 20 sat 98%, hives remained unchanged, raised red present to neck, under chin and on chest. 12:24 ems arrived. care assumed by paramedic. Patient transported to ED
Tested positive for COVID-19 on 11/04/22. I started experiencing  tightness in my chest; body aches; joint pain; low grade fever; chest and nasal congestion. I also have a lingering cough for the past five days.
Headache; soreness at injection site; nausea; fatigue; This is a spontaneous report from a contactable nurse (patient). A 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: Unknown since misplaced/discarded) via intramuscular on 26Dec2020 17:30 on left arm at a single dose for COVID-19 immunization. The patient medical history included anxiety and attention deficit hyperactivity disorder (ADHD). The patient allergy for reglan. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. Concomitant medications included atomoxetine hydrochloride (STRATTERA) and sertraline hydrochloride (ZOLOFT). The patient experienced Headache, soreness at injection site, nausea, fatigue on 27Dec2020 08:00 AM. The patient received Excedrin as treatment for the events. The outcome of the events was recovering.  Information on the Lot/Batch number has been requested.
on 1/8/21, the day after the vaccination I developed a bad headache, nausea, fatigue, chills, cognitive disfunction.  No fever.  I quickly started to vomit intensely and repeatedly for several hours.  Towards the beginning of the vomiting, I believe I passed out and hit my head on the floor.   I don't recall hitting my head at all but had a large swollen bump on my forward.  My husband said he heard the fall.  I had no food in my system so vomiting  was dry heaves , bile and any water I was able to drink.  Symptoms decreased over the next 4-5 hours.  I still  have a more mild headache and slight nausea on 1/11/21.
had 9 allergic reactions which are severe; This is a spontaneous report from a non-contactable consumer via Pfizer sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, Batch/Lot Number: not reported) via on an unspecified route of administration on 17Apr2021 as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced 9 allergic reactions which were severe, and she had been back and forth to the emergency. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sore arm for 2-3 days about 10-15 days out swelling and pain in my finger joints especially the little fingers. As of today- 6 months later much improved. It felt like onset of arthritis.
Redness area 3 inches by 3 inches, itchy, hot, swelling.
8 days post MMR woke crying/lt sided seizures (mild per mom); EMTs called; no LOC but did becoome sl cyanotic around the lips; sz stopped w/ IV Ativan/Dilantin; Unsteady gait for several days; had sl fever/rash on arms; t99-100;
Bodyache , chills, Diarrhea , headache , fatigue ,  was tested for Covid on the 28th and was confirmed positive
short of breathe, body aches, chills, ear aches cough, congestion, fatique